Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension
- RxCUI
- 833463
- RxNorm name
- Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension
- Display name
- Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension
- Full name
- Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:04
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TACLONEX | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | LEO Pharma Inc. | 757c914f-dd8d-43cc-a973-212d591af4af | 2017-11-30 | Warnings, Adverse reactions | 833463 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 757c914f-dd8d-43cc-a973-212d591af4af | Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension | SY | 25 | These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX ® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006 | 20171130 |
| 757c914f-dd8d-43cc-a973-212d591af4af | betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion [Taclonex] | SBD | 25 | These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX ® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006 | 20171130 |
| 757c914f-dd8d-43cc-a973-212d591af4af | Taclonex Scalp (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Suspension | PSN | 25 | These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX ® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006 | 20171130 |
| d61c7acb-a64f-46ee-b125-0c80d3b35585 | Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension | SY | 1 | These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006 | 20100818 |
| d61c7acb-a64f-46ee-b125-0c80d3b35585 | betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion [Taclonex] | SBD | 1 | These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006 | 20100818 |
| d61c7acb-a64f-46ee-b125-0c80d3b35585 | Taclonex Scalp (calcipotriene 0.005 % / betamethasone dipropionate 0.064 % ) Topical Suspension | PSN | 1 | These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006 | 20100818 |